NRAS and melanoma: To investigate the potential synergistic effect of prenylation inhibition with cytotoxic therapy, ZA treatment was applied concurrently with DTIC or cisplatin on three human melanoma cell lines with BRAF or NRAS mutation or harboring no mutations of these genes.